MiMedx Group, Inc. (MDXG)
3.91
-0.02
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
3.905
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price : 3.91 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.90 | 3.93 | 3.85 | 3.91 | 1.263M |
| Oct 22, 2026 | 3.70 | 4.025 | 3.67 | 3.93 | 1.576M |
| Oct 21, 2026 | 4.20 | 4.20 | 3.73 | 3.74 | 2.604M |
| Oct 20, 2026 | 4.40 | 4.46 | 4.21 | 4.23 | 1.633M |
| Oct 19, 2026 | 4.44 | 4.47 | 4.26 | 4.38 | 2.687M |
| Oct 16, 2026 | 4.66 | 4.69 | 4.40 | 4.43 | 2.728M |
| Oct 15, 2026 | 4.76 | 4.875 | 4.655 | 4.68 | 1.331M |
| Oct 14, 2026 | 4.65 | 4.74 | 4.64 | 4.70 | 1.635M |
| Oct 13, 2026 | 4.86 | 4.87 | 4.68 | 4.69 | 972932.0 |
| Oct 12, 2026 | 4.68 | 4.84 | 4.63 | 4.83 | 625570.0 |
| Oct 09, 2026 | 4.58 | 4.695 | 4.58 | 4.67 | 391116.0 |
| Oct 08, 2026 | 4.58 | 4.625 | 4.475 | 4.62 | 1.076M |
| Oct 07, 2026 | 4.58 | 4.68 | 4.57 | 4.61 | 821148.0 |
| Oct 06, 2026 | 4.59 | 4.65 | 4.48 | 4.62 | 1.050M |
| Oct 05, 2026 | 4.58 | 4.695 | 4.55 | 4.55 | 894726.0 |
| Oct 02, 2026 | 4.69 | 4.69 | 4.485 | 4.59 | 1.370M |
| Oct 01, 2026 | 4.65 | 4.68 | 4.57 | 4.64 | 1.189M |
| Sep 30, 2026 | 4.70 | 4.70 | 4.565 | 4.66 | 1.029M |
| Sep 29, 2026 | 4.65 | 4.685 | 4.58 | 4.67 | 901198.0 |
| Sep 28, 2026 | 4.655 | 4.725 | 4.55 | 4.68 | 881299.0 |
| Sep 25, 2026 | 4.71 | 4.71 | 4.40 | 4.67 | 1.460M |
| Sep 24, 2026 | 4.81 | 4.82 | 4.66 | 4.71 | 1.022M |
| Sep 23, 2026 | 4.93 | 4.99 | 4.67 | 4.77 | 1.003M |
| Sep 22, 2026 | 4.81 | 4.94 | 4.78 | 4.93 | 1.032M |
| Sep 21, 2026 | 4.79 | 4.84 | 4.75 | 4.81 | 915909.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 21.42 |
| Perspective Therapeutics, Inc. | 1.61 |
| ABVC BioPharma, Inc. | 1.04 |
| Enovis Corp. | 21.08 |
| Edwards Lifesciences Corp. | 89.07 |
Price Related Metrics
| PE Ratio | 98.99 |
| PS Ratio | 1.641 |
| Price to Book Value | 2.638 |
| Price to Free Cash Flow | 13.77 |
| Earnings Yield | 1.01% |
| Market Cap | 569.78M |
| Operating PE Ratio | 66.58 |
| Normalized PE Ratio | 99.24 |